Clinical Trial Update: Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

View source ↗

Summary

A post-marketing surveillance study of Telmisartan (Micardis) in hypertension has completed, reporting safety and real-world efficacy observations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED